Shell USA Inc. and Shell Midstream Partners L.P. Seal the Deal: A Match Made in Merger Heaven!

Shell USA, Inc. and Shell Midstream Partners, L.P. Reached a Definitive Merger Agreement Exciting News in the World of Energy! Well folks, hold onto your hats because there’s some big news coming out of Houston today! Shell USA, Inc. and Shell Midstream Partners, L.P. have officially announced that they have reached a definitive agreement and…

Read More

Attention Investors: Don’t Miss Out on the Outset Medical Inc. Class Action Lawsuit Deadline – We’ve Got You Covered!

Feeling the Deadline Pressure? Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline The Countdown Begins Are you an investor who purchased or acquired Outset Medical, Inc. (NASDAQ: OM) common stock between September and now? If so, you may want to pay attention to the upcoming deadline of September 6, 2022. Glancy Prongay &…

Read More

Breaking News: Heartland Financial USA Inc. (HTLF) Releases Quarterly and Year-to-Date Results as of June 30, 2022

Heartland Financial USA, Inc. (“HTLF”) Reports Quarterly and Year to Date Results as of June 30, 2022 Highlights and Developments Heartland Financial USA, Inc. (“HTLF”) has reported impressive quarterly results as of June 30, 2022. The company experienced a quarterly loan growth of $551.9 million, representing a 5% increase, excluding Paycheck Protection Program (“PPP”) loans….

Read More

Meet the 2022 Chief Financial Officer of the Year: Cingulate’s Louis G. Van Horn, as Recognized by the Kansas City Business Journal

Kansas City Business Veteran, Two-Time Award Winner, Helped Lead Cingulate to 2021 IPO KANSAS CITY, Kan., July 25, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chief…

Read More

Unlocking the Potential: The Growing Importance of Point-of-Care Coagulation Testing Devices in Managing Chronic Diseases

Rise in Prevalence of Cancer and Heart Diseases Leading to Revenue-Generation Opportunities in Healthcare Market Introduction The global healthcare market is witnessing a significant rise in the prevalence of cancer and heart diseases, leading to increased demand for point-of-care coagulation testing devices. According to a recent study by Transparency Market Research (TMR), the global market…

Read More

Meet the Newest Addition to Enochian Biosciences: Dr. Richard Whitley, Our Senior Scientific Advisor!

Funny and Quirky News: Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) Get ready to meet the newest addition to the Enochian BioSciences team, Dr. Richard Whitley! Today, Enochian BioSciences (the Company) announced that Dr. Richard (Rich) Whitley, M.D., of the University of…

Read More

PSB Holdings Inc. Soars in Second Quarter 2022: Earnings Reach $3.2 Million or $0.72 Per Share, with 5.7% Loan Expansion!

PSB Holdings, Inc. Reports Second Quarter 2022 Earnings PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ) Achieves Strong Results in Second Quarter Wausau, Wis., July 25, 2022 (GLOBE NEWSWIRE) – PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported second quarter earnings ending June 30, 2022…

Read More

Mark Your Calendars: Assertio Holdings Inc. to Unveil Second Quarter 2022 Financial Results on August 8, 2022

Assertio Holdings, Inc. To Report Second Quarter 2022 Financial Results Lake Forest, Ill., July 25, 2022 Specialty Pharmaceutical Company Assertio Announces Financial Results Release Assertio Holdings, Inc. (“Assertio” or the “Company”), a specialty pharmaceutical company offering differentiated products to patients, has revealed that it will be releasing its second quarter 2022 financial results on Monday,…

Read More